162 related articles for article (PubMed ID: 11116123)
1. Malignant pheochromocytoma. Chromaffin granule transmitters and response to treatment.
Rao F; Keiser HR; O'Connor DT
Hypertension; 2000 Dec; 36(6):1045-52. PubMed ID: 11116123
[TBL] [Abstract][Full Text] [Related]
2. Malignant and benign pheochromocytoma: chromaffin granule transmitters and the response to medical and surgical treatment.
Rao F; Keiser HR; O'Connor DT
Ann N Y Acad Sci; 2002 Oct; 971():530-2. PubMed ID: 12438175
[No Abstract] [Full Text] [Related]
3. Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma.
Hsiao RJ; Parmer RJ; Takiyyuddin MA; O'Connor DT
Medicine (Baltimore); 1991 Jan; 70(1):33-45. PubMed ID: 1988765
[TBL] [Abstract][Full Text] [Related]
4. Plasma chromogranin A as a marker of sympathochromaffin activity in humans.
Cryer PE; Wortsman J; Shah SD; Nowak RM; Deftos LJ
Am J Physiol; 1991 Feb; 260(2 Pt 1):E243-6. PubMed ID: 1996627
[TBL] [Abstract][Full Text] [Related]
5. Chromogranin A in familial pheochromocytoma: diagnostic screening value, prediction of tumor mass, and post-resection kinetics indicating two-compartment distribution.
Hsiao RJ; Neumann HP; Parmer RJ; Barbosa JA; O'Connor DT
Am J Med; 1990 Jun; 88(6):607-13. PubMed ID: 2189303
[TBL] [Abstract][Full Text] [Related]
6. Plasma chromogranin A + B, neuropeptide Y and catecholamines in pheochromocytoma patients.
Gröndal S; Eriksson B; Hamberger B; Theodorsson E
J Intern Med; 1991 May; 229(5):453-6. PubMed ID: 2040871
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma.
O'Connor DT; Bernstein KN
N Engl J Med; 1984 Sep; 311(12):764-70. PubMed ID: 6472366
[TBL] [Abstract][Full Text] [Related]
8. Chromogranin A and chromogranin B are sensitive circulating markers for phaeochromocytoma.
Stridsberg M; Husebye ES
Eur J Endocrinol; 1997 Jan; 136(1):67-73. PubMed ID: 9037129
[TBL] [Abstract][Full Text] [Related]
9. Adrenal incidentaloma diagnosed as pheochromocytoma by plasma chromogranin A and plasma metanephrines.
Miehle K; Kratzsch J; Lenders JW; Kluge R; Paschke R; Koch CA
J Endocrinol Invest; 2005 Dec; 28(11):1040-2. PubMed ID: 16483187
[No Abstract] [Full Text] [Related]
10. Plasma chromogranin A in pheochromocytoma, primary hyperparathyroidism and pituitary adenoma in comparison with catecholamine, parathyroid hormone and pituitary hormones.
Kimura N; Miura W; Noshiro T; Mizunashi K; Hanew K; Shimizu K; Watanabe T; Shibukawa S; Sohn HE; Abe K; Miura Y; Nagura H
Endocr J; 1997 Apr; 44(2):319-27. PubMed ID: 9228469
[TBL] [Abstract][Full Text] [Related]
11. Serum chromogranin-alpha immunoradiometric assay in the diagnosis of pheochromocytoma.
Giovanella L; Ceriani L
Int J Biol Markers; 2002; 17(2):130-4. PubMed ID: 12113580
[TBL] [Abstract][Full Text] [Related]
12. Chromogranin A (CgA) in adrenal tumours.
Glinicki P; Jeske W; Bednarek-Papierska L; Kasperlik-Załuska A; Rosłonowska E; Gietka-Czernel M; Zgliczyński W
Endokrynol Pol; 2013; 64(5):358-62. PubMed ID: 24186592
[TBL] [Abstract][Full Text] [Related]
13. Plasma chromogranin A. Initial studies in human hypertension.
O'Connor DT
Hypertension; 1985; 7(3 Pt 2):I76-9. PubMed ID: 3997234
[TBL] [Abstract][Full Text] [Related]
14. A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours.
Bernini GP; Moretti A; Ferdeghini M; Ricci S; Letizia C; D'Erasmo E; Argenio GF; Salvetti A
Br J Cancer; 2001 Mar; 84(5):636-42. PubMed ID: 11237384
[TBL] [Abstract][Full Text] [Related]
15. Chromogranin A, a member of neuroendocrine secretory proteins as a selective marker for laboratory diagnosis of pheochromocytoma.
Bílek R; Šafařík L; Ciprová V; Vlcek P; Lisá L
Physiol Res; 2008; 57 Suppl 1():S171-S179. PubMed ID: 18271679
[TBL] [Abstract][Full Text] [Related]
16. Serum chromogranin-A assay in differential diagnosis of incidentally discovered adrenal masses.
Giovanella L
Anticancer Res; 2005; 25(3A):1547-50. PubMed ID: 16033058
[TBL] [Abstract][Full Text] [Related]
17. Circulating chromogranin A as a diagnostic tool in clinical chemistry.
O'Connor DT; Takiyyuddin MA; Cervenka JH; Parmer RJ; Barbosa JA; Chang YM; Hsiao RJ
Acta Histochem Suppl; 1990; 38():27-33. PubMed ID: 2080246
[TBL] [Abstract][Full Text] [Related]
18. Chromogranin A in human disease.
O'Connor DT; Mahata SK; Taupenot L; Mahata M; Livsey Taylor CV; Kailasam MT; Ziegler MG; Parmer RJ
Adv Exp Med Biol; 2000; 482():377-88. PubMed ID: 11192598
[No Abstract] [Full Text] [Related]
19. Effects of slow-release octreotide on urinary metanephrine excretion and plasma chromogranin A and catecholamine levels in patients with malignant or recurrent phaeochromocytoma.
Lamarre-Cliche M; Gimenez-Roqueplo AP; Billaud E; Baudin E; Luton JP; Plouin PF
Clin Endocrinol (Oxf); 2002 Nov; 57(5):629-34. PubMed ID: 12390337
[TBL] [Abstract][Full Text] [Related]
20. Chromogranin A: posttranslational modifications in secretory granules.
Barbosa JA; Gill BM; Takiyyuddin MA; O'Connor DT
Endocrinology; 1991 Jan; 128(1):174-90. PubMed ID: 1986917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
